Lene Bæksgaard
Copenhagen University Hospital · 89 works · 3,552 citations · h-index 19
Top works
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- Acute tumor lysis syndrome in solid tumors—a case report and review of the literature
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
- Calcium and Vitamin D Supplementation Increases Spinal BMD in Healthy, Postmenopausal Women
- Estimation of Bone Mineral Density by Digital X-ray Radiogrammetry: Theoretical Background and Clinical Testing
- Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
- ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
- Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).
- Body composition analysis by DEXA by using dynamically changing samarium filtration
- Randomized trial of the effects of individual nutritional counseling in cancer patients
- Response of Cortical Bone to Antiresorptive Treatment
- Survival after Adjuvant Chemoradiotherapy or Surgery Alone in Resectable Adenocarcinoma at the Gastro-Esophageal Junction
- Computed Tomography (CT) Perfusion as an Early Predictive Marker for Treatment Response to Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer and Gastric Cancer - A Prospective Study
- Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study
- Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer
- Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
- Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis
- Oncological treatment and outcome of colorectal cancer in Greenland
- Neo-AEGIS (Neoadjuvant Trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Final primary outcome analysis.
- A Nationwide Retrospective Study of Perioperative Chemotherapy for Gastroesophageal Adenocarcinoma: Tolerability, Outcome, and Prognostic Factors